Insulin deficiency, (in T1D or in the latter stages of T2D) attenuates insulin’s and insulin-like growth factor-1’s (IGF-1’s) inhibition of AβOs’ binding to insulin receptor, thus reducing their protection of synapses from AβOs’ toxic effects [109,110]. The gene discussed is IGF1; the disease is type 1 diabetes mellitus.